Reducing Medication Errors
|
|
- Rodney Richard
- 5 years ago
- Views:
Transcription
1 Reducing Medication Errors 1 st July 2015 Dr David Gerrett Senior Pharmacist April 2015 Patient Safety NHS E Manchester MCC
2 Content 1. The Pharmacovigilance landscape 2. MSOs 3. What we know of error from the NRLS 4. The NPSAs 5. Needs a multidisciplinary approach 2
3 Content 1. The Pharmacovigilance landscape 3
4 the development of the National Medication Safety Network improving the number, quality, timeliness of reports maximising local learning and actions improving adherence to the Patient Safety Alert on improving medication error incident reporting and learning developing the role of the medication safety officer 4
5 Directive 2010/84/EU DIRECTIVE 2010/84/EU.the term adverse reaction should be amended to ensure that it covers noxious and unintended effects resulting not only from the authorised use of a medicinal product at normal doses, but also from medication errors and uses outside the terms of the marketing authorisation, including the misuse and abuse of the medicinal product. Originally from Directive 2001/83/EC 5
6 And coming up implementation of. Article 107a(5)of Directive 2001/83/EC outlines the key responsibilities of national competent authorities (MHRA) in relation to the reporting of ADRs associated with medication error: Member States shall ensure that reports of suspected adverse reactions arising from an error associated with the use of a medicinal product that are brought to their attention are made available to the Eudravigilance database and to any authorities, bodies, organisations and/or institutions, responsible for patient safety within that Member State. They shall also ensure that the authorities responsible for medicinal products within that Member State are informed of any suspected adverse reactions brought to the attention of any other authority within that Member State. These reports shall be appropriately identified in the forms referred to in Article 25 of Regulation (EC) No 726/
7 Consultation closed 14/6/2015 7
8 and.additionally CDAOs Controlled Drugs (Supervision of management and use) Regulations 2013 based on the 2006 Regulation but the 2013 Regulations give CDAOs more flexibility and discretion as to how they should discharge their duties and functions than under the previous regime. Specifically, under Duties..CDAO has a variety of duties and functions such as to: ensure the safe and effective use and management of CDs within their own organisations and by anybody or person providing services to their organisation; assess and investigate concerns Controlled Drugs (Supervision of management and use) Regulations 2013 Information about the Regulations 2013;(Feb):13 ttps:// controlled-drugs-regulation-information.pdf 8
9 ADE s, ADR s and Medication Errors No harm Low harm Things we don t know NHS E Medication errors THE FOCUS Preventable (ADEs, ADRs and AEs) NHS E ADE s Potential ADE s Non preventable (ADR, MHRA) Intercepted NHS E 9 Bates DW, Boyle DL, Vander Vliet MB, Schneida J, leape L. Relationship between medication errors and adverse drug events. J. Gen. Intern. Med, 1995;10:
10 ADE s, ADR s and Medication Errors No harm Low harm Things we don t know NHS E Medication errors THE FOCUS Preventable (ADEs, ADRs and AEs) NHS E, MHRA ADE s Potential ADE s Non preventable Intercepted NHS E 10 Bates DW, Boyle DL, Vander Vliet MB, Schneida J, leape L. Relationship between medication errors and adverse drug events. J. Gen. Intern. Med, 1995;10:
11 ADE s, ADR s and Medication Errors No harm NOT MHRA Low harm Things we don t know NHS E Medication errors THE FOCUS Preventable (ADEs, ADRs and AEs) NHS E, MHRA Potential ADE s Intercepted NHS E But NOT MHRA 11
12 Some issues as we see them Greater collaboration between NHS England and MHRA (also CQC, NHS IQ) Need for a way of aggregating the MANY medication PSI datasets to meet EU obligations There is a need to engage the Medication Safety Officer and the CDAO in local medication Patient Safety Incidents (PSIs) as they have similar responsibilities We need the learning to take steps nationally to make it safer for patients Fantastic local practice, but how capitalise on the expertise and know how 12
13 Content 2. MSOs 13
14 Alert! 14
15 Alert! 15
16 Alert! 16
17 >26 th June 2015 We know: Name, Organisation, Type, Region, sub-region, MSO, MDSO Both, MSO 371 (MDSO 289) Devolved Governments 54 PV PSNC other 17
18 MSOs who are they? Essential Network features 1. Acute Sector (159/160?) 2. Mental Health (50/50? community complexity) 3. AT/CCG (75/211) 4. Ambulance (7) 5. Community Pharmacy (18/18 - NPA) 6. Independent Sector (21 growing) 7. Other forces, community trusts 8. Guests (NI, Scotland, Wales. Other) 18
19 MSOs what are they responsible for? Responsibilities should include the following: i. active membership of the National Medication Safety Network; ii. improving reporting and learning of medication error incidents in the organisation; iii. managing medication incident reporting in the organisation. This may entail reviewing all medication incident reports to ensure data quality for local and national learning and where necessary to investigate and find additional information from reporters. Also, to authorise the release of medication error reports to the NRLS each week; iv. receiving and responding to requests for more information about medication error incident reports from the Patient Safety Doman in NHS England and the MHRA; v. work as a member of the medication safety committee to deliver the responsibilities listed in 7.1.4; and, vi. supporting the dissemination of medication safety communications from NHS England and the MHRA throughout the organisation. 19
20 MSOs National focus National support 1. Web Events monthly, 4 Regional events, dedicated conferences 2. UKMI, SPS, MSOs, MHRA 3. New avenues - collation of RCAs 4. Community Pharmacy (quarterly) CCG(?) MH(?) dedicated Web Events 5. Outputs alerts, national learning from RCAs, PSIs resources on www site 20
21 MSOs local and national focus Essential focus 1. Local learning from PSIs 2. Taking National messages and implementing [Alerts] locally 3. Frequency and quality of reporting 4. Training (RCTs, best practice) 5. Conduit between NHS England/MHRA and practice 21
22 To Summarise the MSO role, to: 1. gather evidence of a local learning culture 2. incrementally improve reporting and learning 3. implement better, safer medication practice locally and nationally 4. work together as discrete groups on common topics 5. be the formal conduit between NHS England Patient Safety and practice for medication safety issues 22
23 To focus the role - Most importantly 3. implement better, safer medication practice locally and nationally in collaboration with AOs 5. Implement local system safety improvements and be able to prove it 23
24 Example Schedule 2 CD 16/6/2015 MSO I have been informed by a local pharmacy of four instances where they have received 30 Xenidate XL 36mg tablets with only 29 tablets in the pot. They have informed Mylan and AAH. The batch number and expiry date are the same in every case - B34806B, exp. 10/16. Are you (NHS England) aware of any other cases? 29/6/2015 MHRA have investigated, worked with Industry and issued an Alert yesterday 24
25 Content 3. What we know of error from the NRLS 25
26 The National Reporting and Learning System 26
27 Total Patient Safety Incidents NRLS for March April May June July August September Extraction month 27
28 In context, reported to NRLS reported In 2014 the absolute number of medication reports to the NRLS increased more than in any previous year, representing a 15.6% increase on the year before. 28
29 2014 dataset, not validated Row Labels Administration / supply of a medicine from a clinical area Patient Grand 2013 Death Severe Moderate Low No Harm Group (blank) Total % % Prescribing Preparation of medicines in all locations / dispensing in a pharmacy Other Monitoring / follow-up of medicine use Advice Supply or use of over-thecounter (OTC) medicine (blank) Grand Total
30 Content 4. The NPSAs 30
31 NaPSAs Alerting 31
32 Stages of NaPSAs Stage 1 Notification: Alert Alerts organisations to emerging risk. It will be issued very quickly once a new risk had been identified to allow rapid dissemination of information. Stage 2 Notification: Resource Provision of resources to help mitigate risk identified in stage 1 Stage 3 Notification: Directive Makes it mandatory for organisations to have taken actions based on the stage 1 and stage 2 notifications and implement solutions or actions to mitigate that risk. 32
33 Naloxone 33
34 Naloxone hs.uk/getdocument.aspx?pagei d=
35 NHS England Alerts
36 Content 5. Needs a multidisciplinary approach 36
37 On the shoulders of others 37
38 MSO Survey Results December 2014 Anonymous responses (useable, cleaned) Survey provided basic stats and qualitative gold 38
39 39
40 40
41 Experience (years) or Time (hours/week) (N=132)/179)
42 No allocated time. Added to current role with no extra resource to overstretched team. Added to risk register as impact of this new developing role not fully understood (Count missing) 2 hours a week. would do longer if I had the time. Some weeks is more than others (Count 2) This is difficult there is no single MSO multiple people are involved (Count missing) MSO duties carried out by number of individuals & we aren't covering everything required, eg monthly sign off!! (Count missing) 42
43 Experience About 5 years direct experience with patient safety, interspersed with 10 years of clinical practice. (Count 5) worked as a pharmacist for 25 years not had a specific role on patient safety but all roles have had a patient safety element eg practice support pharmacist, dispensing role within hospitals (Count missing) Qualified for 27 years as clinical pharmacist and 17 years as Pharm Adviser / Head of medicines management (Count missing) 43
44 Q: What barriers (if any) do you perceive need resolving before medication safety issues can be addressed? Culture should be learning not blame. Systems that support not hinder service delivery IT keeping pace with safety requirements the need for community pharmacies to introduce bar coding at point of dispensing removal of the criminality of dispensing errors getting wider ownership of medication safety outside of pharmacy family / team some proper RCA training would be useful, time limitations. Full buy in from direct patient facing staff at operational level to report issues upwards. Traditionally operational teams have been reluctant to 'land themselves in it' - acknowledge that individual organisations have a large role to play. 44
45 Q: What barriers (if any) do you perceive need resolving before medication safety issues can be addressed? Board level ownership of the patient safety alert for MSO. Lack of hard evidence to support business cases for investment in MSO functions to reduce incidents and harm Ease of access to information and identifying the relevant sources (clinical notes). Awareness by other clinical staff of this role and authority that it should have to investigate and call to task. time / my capacity to undertake the role effectively with my other duties 45
46 Q: What barriers (if any) do you perceive need resolving before medication safety issues can be addressed? Overlap between NRLS categories so medication incidents could also be reported in other categories, therefore any learning lost. Too much time spent trying to avoid severe harm or never event criteria rather than using them as a rich learning experience (I suspect the same may happen due to duty of candour with moderate harm events). Still waiting for central standard medicines library. Attitude of press/media to patient harm is unhelpful and would benefit from investment. Could patient safety alerts also be sent to MSO as well via the CAS system? Vacancies within my team 46
47 Q: In your opinion, what are the most pressing medication patient safety issues that we need to tackle Nationally Insulin is still the number one issue within our Trust. I feel that we do better with warfarin. NOACs probably need looking at as we have had several incidents involving them. Communication at the interface between primary & secondary care slips and lapses by staff who know what they are supposed to do but do not follow processes or forget due to extreme pressures. revisiting NPSA alerts would be very useful review anticoagulation. Appears we may still be getting a high number of incidents. Is this a true national picture, is there anything more we can do? 47
48 Q: In your opinion, what are the most pressing medication patient safety issues that we need to tackle Nationally Medicines reconciliation. Anticoagulation (involving pharmacists with dosing etc). Second checking of IVs etc by nurses (in reality nurses not empowered to speak up if they see a mistake by a colleague, too much faith put in the first nurse and the second checker by the first nurse so items not self checked), NPSA alerts for anticoagulants, taking into account patient self testing and NOACs Nationally we need to be able to meet regionally. Perhaps strategic area authorities need to dictate that regional groups form. Currently there seem to be areas where good work is going on but we do not have a strong enough network to share between regions 48
49 Medication Incident Report to MHRA via Yellow Card Scheme Analysis & regulatory action Adverse drug reactions (ADRs) but not Medication errors Healthcare Professionals and Patients Identify and REPORT Medication errors Risk /Complaint Managers Oversight & Quality Assurance OPTION 2 CDAO integrated For CDs Medicines Safety Officer (MSO) Quality Assurance Local Medication Safety Committee Oversight and Support Request additional information Submit reports to NRLS through organisation's system or online e-form MHRA & NHS England Analysis 49
50 But here is the rub In secondary care 80% of medication administration is by nurses In primary care its self-administration or carers Only through the involvement of the full team (inc pateints) can the MSOs have a full impact They can introduce system changes locally but need buy in best if everyone moves forward together! 50
51 The minimum to strive for is Where there is serious harm, for a CD there should be automatic involvement of the CDAO and the MSO and this should be recorded and made available for national learning! 51
52 Content 1. The Pharmacovigilance landscape 2. MSOs 3. What we know of error from the NRLS 4. The NPSAs 5. Needs a multidisciplinary approach 52
53 What you will remember The EU has some big involvement in this Most MSOs are pharmacists and will need help from everybody to improve patient safety There are some Alerts I need to make sure we are doing something about! Need to ensure MSOs and CDAO are talking Oh and david.gerrett@nhs.net (but be mindful of death by ) 53
54 Questions? Many thanks for listening and to HC for the invitation to discuss these matters with you. 54
Reducing Medication Errors: National Update
Reducing Medication Errors: National Update Ahmed Ameer Medication Safety Officer Ahmed.Ameer@NHS.net Safer Medication Practice & Medical Devices Team 27 th January 2015 Agenda 1. Development of the National
More informationImproving the reporting of medication-related safety incidents
Rationale Improving the reporting of medication-related safety incidents Research shows that organisations which regularly report more patient safety incidents usually have a stronger learning culture
More informationSafe medication practice what can we learn from root cause analysis and related methods?
Safe medication practice what can we learn from root cause analysis and related methods? Dr David Gerrett, Senior Pharmacist Patient Safety NHS Improvement Information Day on Medication Errors 20 October
More informationHow to Report Medication Safety Incidents from a GP Practice on the National Reporting and Learning System (NRLS)
pecialist Pharmacy ervice Medicines Use and afety How to Report Medication afety Incidents from a GP Practice on the National Reporting and Learning ystem (NRL) This document provides a quick explanation
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSafeguarding public health. The New PV Legislation its Impact on PV & MI
Safeguarding public health The New PV Legislation its Impact on PV & MI Sarah Vaughan - MHRA PIPA 2013 Manager s Meeting 13 th February 2013 Content Scope of change Key areas - ADR reporting - DDPS to
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationWhat does governance look like in homecare?
What does governance look like in homecare? Dr David Cousins PhD FRPharmS Head of Pa)ent Safety, Healthcare at Home Ltd This Satellite is sponsored by Healthcare at Home Ltd Definitions Clinical governance
More informationExecutive Summary points to consider by organisations providing Primary and Community Health services
pecialist Pharmacy ervice Medicines Use and afety A ummary of Pharmacy upport required to deliver Medicines Optimisation in Primary Care based and Community Health ervices: A guide for Organisational Boards
More informationMy role as a Medication Safety Officer (MSO) Joanna Taylor, Lead Pharmacist Medication Safety, Risk and Compliance
My role as a Medication Safety Officer (MSO) Joanna Taylor, Lead Pharmacist Medication Safety, Risk and Compliance Overview CNWL Trust in context Implementing NHS England PSA - improving medication incident
More informationMedicines Optimisation Patient Safety And Medication Safety. Dr David Cousins Associate Director Medication Safety and Medical Devices
Medicines Optimisation Patient Safety And Medication Safety Dr David Cousins Associate Director Medication Safety and Medical Devices The key elements of medicines optimisation is patient centred; makes
More informationGuidance notes on National Reporting and Learning System official statistics publications
Guidance notes on National Reporting and Learning System official statistics publications September 2017 We support providers to give patients safe, high quality, compassionate care, within local health
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationPatient Falls Metric (2018)
Patient Falls Metric (2018) Falls Unintentionally coming to rest on the ground, floor or other lower surface (NPSA 2010) Include all slips, trips and falls e.g. if a patient is found on the floor, lowered
More informationCorporate Induction: Part 2
Corporate Induction: Part 2 Identification of preventable Adverse Drug Reactions from a regulatory perspective March 1 st 2013, EMA Workshop on Medication Errors Presented by Almath Spooner, Pharmacovigilance
More informationGood Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA
Good Pharmacovigilance Practice Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Content ADR Reporting Definition & Increased scope Transition arrangements
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationData Quality Notes. Dimension 1: Relevance. Dimension 2: Accuracy. Alison Pryce (Senior Statistician).
Author: Data Quality Notes Alison Pryce (Senior Statistician). There are known quality issues that should be borne in mind when interpreting NRLS data. These are described within the context of the six
More informationWhittington Health Trust Board
Executive Offices Direct Line: 020 7288 3939/5959 www.whittington.nhs.uk The Whittington Hospital NHS Trust Magdala Avenue London N19 5NF Whittington Health Trust Board Title: 4 th March 2015 Sign up to
More informationMoving the Green Medicines Bag from the Safety Agenda to QIPP
Moving the Green Medicines Bag from the Safety Agenda to QIPP Jane Hough (ESEE Specialist Pharmacy Services) Fiona Eccleston (PSF Project Manager) Ed England ( Ambulance Service) Facts and figures 97%
More information14 th May Pharmacy Voice. 4 Bloomsbury Square London WC1A 2RP T E
Consultation response Department of Health Rebalancing Medicines Legislation and Pharmacy Regulation: draft orders under section 60 of the Health Act 1999 14 th May 2015 Pharmacy Voice 4 Bloomsbury Square
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationEnsuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING
Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING Contents Page 1.0 Purpose 2 2.0 Definition of medication error
More informationSafeguarding public health. The New PV Legislation. Perspective from a Member State
Safeguarding public health The New PV Legislation Perspective from a Member State Mick Foy Reinforcing patient safety in Europe, Zagreb June 2011 Content Background The new EU PV Package ADR Definition
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationDERBY HOSPITALS NHS FOUNDATION TRUST PROJECT FINAL SUMMARY REPORT. Purchasing for Safety - Injectable Medicines
DERBY HOSPITALS NHS FOUNDATION TRUST PROJECT FINAL SUMMARY REPORT Purchasing for Safety - Injectable Medicines Document Control Version Status Date Author and summary of changes 0.1 Draft 07 Mar08 Tom
More informationBulletin Independent prescribing information for NHS Wales
Bulletin Independent prescribing information for NHS Wales Medicines-related admissions February 2015 Although medicines play an important role in the management of chronic and acute illnesses, they can
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More informationPolicy for the Reporting and Management of Incidents Including Serious Incidents. Version Number: 006
CONTROLLED DOCUMENT Policy for the Reporting and Management of Incidents Including Serious Incidents CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the principles
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationINDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board
INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationTrust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:
Trust Policy and Procedure Document Ref. No: PP (17) 283 Central Alerting System (CAS) Policy and Procedure For use in: For use by: For use for: Document owner: Status: All areas of the Trust including
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationMedication Error Incidents reporting survey. Consultation questions
Medication Error Incidents reporting survey Consultation questions The MHRA and NHS England have formed a strategic partnership to improve reporting and learning in the field of medication safety. This
More informationHealthwatch England Escalation Guidance
Healthwatch England Escalation Guidance This guidance provides information on how to do four things: 1) Collating people s views and experiences of care services from local Healthwatch 2) Highlighting
More informationSAFE Standard of Care
SAFE Standard of Care THE NEW UK STANDARD OF CARE BANISH MEDICATION ERRORS We all know that when medication is prescribed, dispensed and administered correctly it can dramatically improve the quality of
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationReducing Risk: Mental health team discussion framework May Contents
Reducing Risk: Mental health team discussion framework May 2015 Contents Introduction... 3 How to use the framework... 4 Improvement area 1: Unscheduled absence and managing time off the ward... 5 Improvement
More informationPre-registration. e-portfolio
Pre-registration e-portfolio 2013 2014 Contents E-portfolio Introduction 3 Performance Standards 5 Page Appendix SWOT analysis 1 Start of training plan 2 13 week plan 3 26 week plan 4 39 week plan 5 Appraisal
More informationNon Medical Prescribing Policy Register No: Status: Public
Non Medical Prescribing Policy Policy Register No: 07049 Status: Public Developed in response to: Department of Health Policies, Prescribing Guidance & Legislation Contributes to CQC Outcome: 9 Consulted
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationUnlicensed Medicines Policy
Who Should Read This Policy Target Audience All Consultant/Senior Medical Staff All Junior Medical Staff All Non-Medical Prescribers All Pharmacy Staff All Nursing Staff Version 1.0 February 2016 Ref.
More informationGuidance notes for patient safety and pharmacovigilance in patient support programmes
Guidance notes for patient safety and pharmacovigilance in patient support programmes Authors: The ABPI Pharmacovigilance Expert Network Version: 2.14 Date: March 2018 Acknowledgements: We thank the many
More informationMedicine Management Policy
INDEX Prescribing Page 2 Dispensing Page 3 Safe Administration Page 4 Problems & Errors Page 5 Self Administration Page 7 Safe Storage Page 8 Controlled Drugs Best Practice Procedure Page 9 Controlled
More informationGuidance on NHS Wales Patient Safety Solutions. December 2014
Guidance on NHS Wales Solutions December 2014 Digital ISBN 978-1-4734-2546-0 Crown copyright 2014 WG23419 Contents Background 1 Compliance 2 Appendix 1 Template and explanatory notes for a Alert 3 Appendix
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationSAFEGUARDING CHILDREN POLICY
SAFEGUARDING CHILDREN POLICY The child s needs are paramount, and the needs and wishes of each child, be they a baby or infant, or an older child, should be put first Working Together 2015 p 8 Keeping
More informationTHE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016
THE CODE Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland Effective from 1 March 2016 PRINCIPLE 1: ALWAYS PUT THE PATIENT FIRST PRINCIPLE 2: PROVIDE A SAFE
More informationVersion: 3.0. Effective from: 29/08/2012
Policy No: RM51 Version: 3.0 Name of policy: Learning from Experience Policy A systematic approach to incident, complaint and clai management, analysis and sharing safety lessons Effective from: 29/08/2012
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More information- Patients Own Drugs - Missed Doses - Anticoagulants - Medication Safety Officer role
EAHP ACADEMY SEMINAR 30 Sept - 1 Oct 2016, Bucharest From Medicines Reconciliation to Medicines Optimisation - Patients Own Drugs - Missed Doses - Anticoagulants - Medication Safety Officer role Jane Smith,
More informationSupporting information for appraisal and revalidation: guidance for psychiatry
Supporting information for appraisal and revalidation: guidance for psychiatry Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction The purpose of revalidation
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate Quality standards Process guide
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Quality standards Process guide December 2014 Quality standards process guide Page 1 of 44 About this guide This guide
More informationResponsible pharmacist requirements: What activities can be undertaken?
requirements: What activities can be undertaken? Status of this document This guidance is intended to assist the profession in implementing the responsible requirements within registered premises. 1 Appendix
More informationOverseeing the safer management of controlled drugs
Overseeing the safer management of controlled drugs 11 th May 2017 Geraldine Yates Medicines Manager, Central Region Robert Allan Controlled Drugs Officer, National Our brief Assessing and overseeing how
More informationSELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING
CLINICAL PROTOCOL SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING RATIONALE Medication errors can cause unnecessary
More informationJOB DESCRIPTION. The post holder will focus on urgent care but may take responsibility for specialist projects and other services when required.
JOB DESCRIPTION Job Title: Deputy Medical Director Reports to: Medical Director, Urgent Care Location: Across Greenbrook urgent care services. Key Working Relationships: Director of Operations; Director
More informationPractising as a midwife in the UK
Practising as a midwife in the UK An overview of midwifery regulation CONTENTS Introduction 3 Section 1: Education 4 Section 2: Joining the register and maintaining registration 6 Section 3: Standards
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationBest Practice Statement ~ March Patient Group Directions
Best Practice Statement ~ March 2006 Patient Group Directions NHS Quality Improvement Scotland 2005 ISBN 1-84404-403-3 First published March 2006 NHS Quality Improvement Scotland (NHS QIS) consents to
More information4. Hospital and community pharmacies
4. Hospital and community pharmacies As FIP is the international professional organisation of pharmacists, this paper emphasises the role of the pharmacist in ensuring and increasing patient safety. The
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 1.1 Short title Medicines
More informationThe Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales.
Welsh Affairs Committee. Purpose: The Welsh NHS Confederation s response to the inquiry into cross-border health arrangements between England and Wales. Contact: Nesta Lloyd Jones, Policy and Public Affairs
More informationNRLS organisation patient safety incident reports: commentary
NRLS organisation patient safety incident reports: commentary March 2018 We support providers to give patients safe, high quality, compassionate care within local health systems that are financially sustainable.
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationCompleting the NPA online Patient Safety Incident Report form: 2016
The National Pharmacy Association (NPA) Patient Safety Incident report form can be used within the community pharmacy to log patient safety incidents. The online form should not include any patientidentifiable
More informationMount Pleasant School Supporting Children with Medical Conditions
Mount Pleasant School Supporting Children with Medical Conditions This document must be read in conjunction with Defence Instruction Notice for Health Provision in BFSAI. This school is an inclusive community
More informationProcedure to Allow Nursing Staff to Dispense Leave and Discharge Medication
Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Version 2 minor update June 2013 Procedure Number Replaces Policy No. Ratifying Committee N/a PPPF Date Ratified April 2009 Minor
More informationFORTH VALLEY CLINICAL AND CARE GOVERNANCE FRAMEWORK
HEALTH AND SOCIAL CARE INTEGRATION: FORTH VALLEY CLINICAL AND CARE GOVERNANCE FRAMEWORK The Scottish Government, National Health and Wellbeing Outcomes: A framework for improving the planning and delivery
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationJoint framework: Commissioning and regulating together
With support from NHS Clinical Commissioners Regulation of General Practice Programme Board Joint framework: Commissioning and regulating together A practical guide for staff January 2018 Publications
More informationSupporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014
Supporting information for appraisal and revalidation: guidance for Occupational Medicine, June 2014 Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. General Introduction
More informationTackling the challenge of non-adherence
Tackling the challenge of non-adherence 2 How is adherence defined? WHO definition: the extent to which a person s behaviour taking medication, following a diet and/or executing lifestyle changes corresponds
More informationGPhC response to the Rebalancing Medicines Legislation and Pharmacy Regulation: draft Orders under section 60 of the Health Act 1999 consultation
GPhC response to the Rebalancing Medicines Legislation and Pharmacy Regulation: draft Orders under section 60 of the Health Act 1999 consultation Background The General Pharmaceutical Council (GPhC) is
More informationAll Wales Multidisciplinary Medicines Reconciliation Policy
All Wales Multidisciplinary Medicines Reconciliation Policy June 2017 This document has been prepared by the Quality and Patient Safety Delivery Group of the All Wales Chief Pharmacists Group, with support
More informationReconciliation of Medicines on Admission to Hospital
Reconciliation of Medicines on Admission to Hospital Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationPatient Safety. At the heart of all we do
Patient Safety At the heart of all we do Introduction from our Medical Director Over the last 15 years it has been recognised that patient safety problems exist throughout the NHS as they do in every health
More informationSafeguarding Adults Policy March 2015
Safeguarding Adults Policy 2015-16 March 2015 Document Control: Description Comment Title Document Number 1 Author Lindsay Ratapana Date Created March 2015 Date Last Amended Version 1 Approved By Quality
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationOur pharmacist led care home service
Our pharmacist led care home service Optimising the medicines of patients who are living in a care home. Suppor t Prescribing Ser vices Commissioning a care home medication review service (PSS) is one
More informationThanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that
Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that hospital. 1 2 3 Note that an actual variance occurs when
More informationGuidance on supporting information for revalidation
Guidance on supporting information for revalidation Including specialty-specific information for medical examiners (of the cause of death) General introduction The purpose of revalidation is to assure
More informationSUPPLEMENTARY PRESCRIBING: PHARMACIST PRACTITIONERS
SUPPLEMENTARY PRESCRIBING: PHARMACIST PRACTITIONERS A Guide for Implementation within NHSScotland Scottish Executive Health Department SUPPLEMENTARY PRESCRIBING: PHARMACIST PRACTITIONERS A Guide for Implementation
More informationBETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS
A2 BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS March 2012 A3 BETTER REGULATION OF MEDICINES INITIATIVE (BROMI) FIFTH REPORT ON PROGRESS Chief Executive s foreword In January
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationCommunity Pharmacy Multi-compartment Compliance Aids Audit
Community Pharmacy Multi-compartment Compliance Aids Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must
More informationPresentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting
Presentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting Gatineau, Quebec June 10, 2011 (Amended for Project Web Page) Canadian Pharmaceutical Bar Coding Project
More informationSupervising pharmacist independent
Supervising pharmacist independent prescribers in training Summary of responses to the discussion paper Introduction 1. Two of the General Pharmaceutical Council s core activities are setting standards
More informationNATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas
NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT Safer Use of Injectable Medicines In Near-Patient Areas Wide Stake Holder Consultation January March 2006 The NPSA is undertaking a wide stake
More informationMMPR034 MEDICINES RECONCILIATION ON ADMISSION TO HOSPITAL PROTOCOL
MMPR034 MEDICINES RECONCILIATION ON ADMISSION TO HOSPITAL PROTOCOL 1 Table of Contents Why we need this Protocol...3 What the Protocol is trying to do...3 Which stakeholders have been involved in the creation
More informationCORPORATE POLICY & PROCEDURE CPP23 No1. Serious Incident Requiring Investigation Policy August 2017
CORPORATE POLICY & PROCEDURE CPP23 No1 Serious Incident Requiring Investigation Policy August 2017 DOCUMENT INFORMATION Author: Paul Cooke, Investigation Manager Ratifying committee/group: SIRI REVIEW
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationMedDRA User Group. Paris, April 16, 2015 Victoria Newbould, European Medicines Agency. An agency of the European Union
MedDRA User Group Paris, April 16, 2015 Victoria Newbould, European Medicines Agency An agency of the European Union HMA meeting 28 November 2013 HMA agreed with the deliverables to be completed over the
More informationManagement of Reported Medication Errors Policy
Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust
More information